Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China · Delayed Price · Currency is CNY 62.38
+2.33 (3.88%)
Jul 31, 2026, 3:04 PM CST
SHE:002653 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,810 | 1,386 | 1,056 | 1,169 | 775.39 | 575.11 |
Trading Asset Securities | 130 | - | 150.13 | 160.06 | - | - |
Cash & Short-Term Investments | 1,940 | 1,386 | 1,206 | 1,329 | 775.39 | 575.11 |
Cash Growth | 49.46% | 14.94% | -9.23% | 71.37% | 34.82% | -53.41% |
Accounts Receivable | 892.13 | 1,033 | 1,077 | 883.9 | 803.79 | 569.97 |
Other Receivables | 26.93 | 25.33 | 40.35 | 46.79 | 47.14 | 78.5 |
Receivables | 919.06 | 1,058 | 1,117 | 930.69 | 850.93 | 648.47 |
Inventory | 328.46 | 306.77 | 271.61 | 281.29 | 346 | 259.95 |
Prepaid Expenses | - | 10.09 | 22.55 | - | - | - |
Other Current Assets | 68.71 | 72.87 | 112.53 | 100.02 | 81.32 | 64.9 |
Total Current Assets | 3,256 | 2,834 | 2,730 | 2,641 | 2,054 | 1,548 |
Property, Plant & Equipment | 854.43 | 853.21 | 917.09 | 996.04 | 1,074 | 1,137 |
Long-Term Investments | 426.58 | 177.99 | 146.99 | 232.46 | 422.17 | 381.19 |
Other Intangible Assets | 1,474 | 1,518 | 1,277 | 751.23 | 708.33 | 682.47 |
Long-Term Deferred Tax Assets | 173.52 | 204.7 | 177.23 | 148.24 | 126.08 | 83.57 |
Long-Term Deferred Charges | 1,003 | 957.53 | 1,107 | 1,427 | 1,233 | 822.42 |
Other Long-Term Assets | 471.25 | 465.62 | 443.95 | 457.37 | 430.15 | 350.51 |
Total Assets | 7,660 | 7,011 | 6,798 | 6,653 | 6,048 | 5,005 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 156.54 | 165.85 | 195.89 | 208.99 | 242.44 | 301.4 |
Accrued Expenses | 83.66 | 261.19 | 190.48 | 200.09 | 136.68 | 120.63 |
Short-Term Debt | 27.22 | 79.95 | 242.57 | 99.98 | 484.69 | 452.18 |
Current Portion of Long-Term Debt | 1,152 | 880.74 | 728.41 | 833.59 | 295.4 | 325.78 |
Current Portion of Leases | - | 7.84 | 10.27 | 7.41 | 6.64 | 8 |
Current Income Taxes Payable | 47.12 | 8.92 | 5.49 | 16.08 | 16.1 | 1.71 |
Current Unearned Revenue | 15.01 | 16.72 | 20.87 | 14.61 | 26.96 | 28.44 |
Other Current Liabilities | 133.81 | 146.03 | 174.23 | 123.23 | 279.64 | 279.98 |
Total Current Liabilities | 1,615 | 1,567 | 1,568 | 1,504 | 1,489 | 1,518 |
Long-Term Debt | 1,036 | 1,002 | 925 | 854.68 | 1,320 | 452.41 |
Long-Term Leases | 22.33 | 9.55 | 4.14 | 10.85 | 4.52 | 10.91 |
Long-Term Unearned Revenue | 134.53 | 134.77 | 95.06 | 108.47 | 98.52 | 102.54 |
Long-Term Deferred Tax Liabilities | 9.76 | 9.62 | 3.77 | 4.01 | 2.53 | 1.11 |
Other Long-Term Liabilities | - | - | - | 0.38 | - | - |
Total Liabilities | 2,817 | 2,723 | 2,596 | 2,482 | 2,914 | 2,085 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,120 | 1,120 | 1,120 | 1,114 | 1,076 | 1,077 |
Additional Paid-In Capital | 1,093 | 1,085 | 953.57 | 853.38 | 100.82 | 97.62 |
Retained Earnings | 2,690 | 2,136 | 2,180 | 2,210 | 1,807 | 1,733 |
Treasury Stock | -56.66 | -56.66 | -80.94 | -9.15 | -24.44 | -38.31 |
Comprehensive Income & Other | -1.86 | 5.77 | 40.55 | 11.86 | 76.41 | -26.82 |
Total Common Equity | 4,844 | 4,290 | 4,213 | 4,180 | 3,036 | 2,842 |
Minority Interest | -2.01 | -2 | -11.09 | -9.36 | 97.68 | 78.27 |
Shareholders' Equity | 4,842 | 4,288 | 4,202 | 4,171 | 3,133 | 2,920 |
Total Liabilities & Equity | 7,660 | 7,011 | 6,798 | 6,653 | 6,048 | 5,005 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,237 | 1,980 | 1,910 | 1,807 | 2,111 | 1,249 |
Net Cash (Debt) | -296.6 | -593.2 | -704.22 | -477.74 | -1,336 | -674.16 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.27 | -0.53 | -0.62 | -0.44 | -1.25 | -0.63 |
Filing Date Shares Outstanding | 1,109 | 1,155 | 1,159 | 1,048 | 1,036 | 1,091 |
Total Common Shares Outstanding | 1,109 | 1,155 | 1,159 | 1,048 | 1,036 | 1,091 |
Working Capital | 1,641 | 1,267 | 1,162 | 1,137 | 565.09 | 30.32 |
Book Value Per Share | 4.37 | 3.71 | 3.63 | 3.99 | 2.93 | 2.61 |
Tangible Book Value | 3,370 | 2,772 | 2,937 | 3,429 | 2,327 | 2,159 |
Tangible Book Value Per Share | 3.04 | 2.40 | 2.53 | 3.27 | 2.25 | 1.98 |
Buildings | - | 930.28 | 931.33 | 965.52 | 922.14 | 931.62 |
Machinery | - | 818.33 | 789.01 | 748.62 | 709.94 | 677.15 |
Construction In Progress | - | 0.6 | 6.73 | 5.87 | 97.9 | 88.54 |